| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.26 | 3e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 4e-06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |